天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Struktur
1220696-61-6
CAS-Nr.
1220696-61-6
Englisch Name:
2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Synonyma:
2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)pyridine
CBNumber:
CB63748093
Summenformel:
C12H17BFNO2
Molgewicht:
237.0782832
MOL-Datei:
1220696-61-6.mol

2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Eigenschaften

L?slichkeit
soluble in No data available

Sicherheit

2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

2-(Fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine is used to prepare 8-substituted isoquinoline derivatives as IKKβ kinase inhibitors for treating and/or preventing articular rheumatism, acute or chronic inflammation, or cancer in mammals.

2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou Chukai Pharma Tech Co.,Ltd
+86-15151706780; +8615062531973
2279973922@qq.com China 391 58
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44806 58
Suzhou Chukai PharmaTech 0512-88812066
wenlongfcb@qq.com China 350 58
United States Biological --
sales@advtechind.com United States 6075 58

  • 2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
  • 2-(fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)pyridine
  • 1220696-61-6
Copyright 2019 ? ChemicalBook. All rights reserved